Published in Arch Dermatol on November 01, 2003
Mast cell activation contributes to sickle cell pathobiology and pain in mice. Blood (2013) 1.94
Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest (2006) 1.90
Endothelin receptors and pain. J Pain (2009) 1.27
Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc (2011) 1.27
Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc (2011) 1.10
Mast cell-derived tumor necrosis factor can promote nerve fiber elongation in the skin during contact hypersensitivity in mice. Am J Pathol (2006) 1.01
Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis. Yonsei Med J (2010) 0.99
Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema. J Clin Aesthet Dermatol (2012) 0.97
A retrospective analysis of amputation rates in diabetic patients: can lower extremity amputations be further prevented? Cardiovasc Diabetol (2012) 0.96
Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol (2004) 0.95
Without nerves, immunology remains incomplete -in vivo veritas. Immunology (2005) 0.94
Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea. J Clin Aesthet Dermatol (2012) 0.88
TRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis. J Immunol (2013) 0.87
Rosacea: The cytokine and chemokine network. J Investig Dermatol Symp Proc (2011) 0.87
Cutaneous endothelin-A receptors elevate post-incisional pain. Pain (2007) 0.87
Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates. Acta Derm Venereol (2012) 0.86
Neuroimmune mechanisms in patients with atopic dermatitis during chronic stress. J Eur Acad Dermatol Venereol (2008) 0.84
Involvement of tumour necrosis factor-alpha in Clostridium perfringens beta-toxin-induced plasma extravasation in mice. Br J Pharmacol (2008) 0.84
Staphylococcal enterotoxin B causes proliferation of sensory C-fibers and subsequent enhancement of neurogenic inflammation in rat skin. J Infect Dis (2011) 0.84
Retinoids activate the irritant receptor TRPV1 and produce sensory hypersensitivity. J Clin Invest (2013) 0.83
Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo. Am J Pathol (2010) 0.81
The anti-inflammatory effect of diclofenac is considerably augmented by topical capsaicinoids-containing patch in carrageenan-induced paw oedema of rat. Inflammopharmacology (2013) 0.79
Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases. J Allergy Clin Immunol (2016) 0.77
Thermographic evaluation of hind paw skin temperature and functional recovery of locomotion after sciatic nerve crush in rats. Clinics (Sao Paulo) (2011) 0.77
Stress-induced mast cell activation in glabrous and hairy skin. Mediators Inflamm (2014) 0.76
The evaluation of prevalence of fibromyalgia in patients with chronic urticaria. Med Sci Monit (2013) 0.76
Low-level laser therapy and light-emitting diode effects in the secretion of neuropeptides SP and CGRP in rat skin. Lasers Med Sci (2013) 0.76
Stress induced neuroendocrine-immune plasticity: A role for the spleen in peripheral inflammatory disease and inflammaging? Dermatoendocrinol (2012) 0.75
The effect of topical capsaicin-induced sensitization on heat-evoked cutaneous vasomotor responses. Int J Physiol Pathophysiol Pharmacol (2013) 0.75
Langerhans cells regulate cutaneous innervation density and mechanical sensitivity in mouse footpad. Neurosci Lett (2014) 0.75
Serratus muscle stimulation effectively treats notalgia paresthetica caused by long thoracic nerve dysfunction: a case series. J Brachial Plex Peripher Nerve Inj (2009) 0.75
Alstonia scholaris R. Br. Significantly Inhibits Retinoid-Induced Skin Irritation In Vitro and In Vivo. Evid Based Complement Alternat Med (2011) 0.75
Topical royal jelly alleviates symptoms of pruritus in a murine model of allergic contact dermatitis. Pharmacogn Mag (2013) 0.75
Neuroprotective effect of erythropoietin against pressure ulcer in a mouse model of small fiber neuropathy. PLoS One (2014) 0.75
Presence of Mast Cells and Mast Cell Degranulation in Scalp Biopsies of Telogen Effluvium. Int J Trichology (2017) 0.75
The neurobiology of itch. Nat Rev Neurosci (2006) 3.25
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med (2010) 2.98
Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci (2003) 2.94
Separate peripheral pathways for pruritus in man. J Neurophysiol (2008) 2.64
Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain (2005) 2.42
Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain (2003) 2.18
Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol Cell Biol (2003) 2.17
Human keratinocytes express functional CD14 and toll-like receptor 4. J Invest Dermatol (2002) 1.94
Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest (2006) 1.90
Systolic anterior motion of the mitral valve with left ventricular outflow tract obstruction: three cases of acute perioperative hypotension in noncardiac surgery. Anesth Analg (2005) 1.75
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis (2013) 1.74
Epidermal nerve fibers modulate keratinocyte growth via neuropeptide signaling in an innervated skin model. J Invest Dermatol (2013) 1.67
High spontaneous activity of C-nociceptors in painful polyneuropathy. Pain (2012) 1.62
Tumor immune escape by the loss of homeostatic chemokine expression. Proc Natl Acad Sci U S A (2007) 1.58
Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol (2006) 1.53
Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res (2002) 1.52
Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS). Neurosci Lett (2008) 1.50
Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial. Acta Oncol (2006) 1.48
Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat Cell Biol (2002) 1.48
Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol (2012) 1.46
Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol (2007) 1.46
Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain. Nat Med (2009) 1.45
Itch. Lancet (2003) 1.45
Recommendation: daily sun protection in the prevention of chronic UV-induced skin damage. J Dtsch Dermatol Ges (2007) 1.41
Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology (2003) 1.37
Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma. Cancer Res (2002) 1.37
Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg (2004) 1.34
Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol (2006) 1.33
Bradykinin is a potent pruritogen in atopic dermatitis: a switch from pain to itch. Pain (2006) 1.29
Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells. J Leukoc Biol (2008) 1.28
Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol (2008) 1.28
Electrically evoked itch in humans. Pain (2005) 1.25
Pathological C-fibres in patients with a chronic painful condition. Brain (2003) 1.23
Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. FASEB J (2003) 1.22
Drug-induced pruritus: a review. Acta Derm Venereol (2009) 1.20
Beta2 integrins are required for skin homing of primed T cells but not for priming naive T cells. J Clin Invest (2002) 1.18
Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci (2005) 1.18
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis (2014) 1.17
Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum (2003) 1.17
Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B. J Invest Dermatol (2005) 1.16
Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. J Invest Dermatol (2002) 1.12
Neurophysiology of pruritus: cutaneous elicitation of itch. Arch Dermatol (2003) 1.12
Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc (2011) 1.10
Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome. Exp Neurol (2003) 1.10
Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol (2012) 1.09
Neuronal sensitization for histamine-induced itch in lesional skin of patients with atopic dermatitis. Arch Dermatol (2003) 1.09
High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res (2004) 1.09
Interleukin-6 in combination with its soluble IL-6 receptor sensitises rat skin nociceptors to heat, in vivo. Pain (2002) 1.08
Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin. Anesth Analg (2004) 1.07
In vitro and in vivo evaluation of topical formulations of spantide II. AAPS PharmSciTech (2005) 1.06
The impact of opioid-induced hyperalgesia for postoperative pain. Best Pract Res Clin Anaesthesiol (2007) 1.06
Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I. Pain (2009) 1.05
Pathophysiology and treatment of pain in joint disease. Adv Drug Deliv Rev (2006) 1.05
Pathophysiology of itch and new treatments. Curr Opin Allergy Clin Immunol (2011) 1.04
NGF induces non-inflammatory localized and lasting mechanical and thermal hypersensitivity in human skin. Pain (2009) 1.04
Abnormal function of C-fibers in patients with diabetic neuropathy. J Neurosci (2006) 1.04
Neutral endopeptidase inhibition in diabetic wound repair. Wound Repair Regen (2002) 1.04
Differential endogenous pain modulation in complex-regional pain syndrome. Brain (2009) 1.04
Neural signal processing: the underestimated contribution of peripheral human C-fibers. J Neurosci (2002) 1.03
Neurophysiology of pruritus: interaction of itch and pain. Arch Dermatol (2003) 1.03
Prurigo nodularis: systematic analysis of 58 histological criteria in 136 patients. J Cutan Pathol (2009) 1.03
Collagen metabolism is a novel target of the neuropeptide alpha-melanocyte-stimulating hormone. J Biol Chem (2003) 1.02
The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans. Pain (2004) 1.02
Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea. J Invest Dermatol (2011) 1.02
Painful and nonpainful phantom and stump sensations in acute traumatic amputees. J Trauma (2008) 1.01
The effect of the nitric oxide synthase inhibitor N-nitro-L-arginine-methyl ester on neuropeptide-induced vasodilation and protein extravasation in human skin. J Vasc Res (2003) 1.01
Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans. Anesthesiology (2006) 1.00
Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans. Pain (2003) 0.99
Endothelin 1 activates and sensitizes human C-nociceptors. Pain (2007) 0.99
Neural fractalkine expression is closely linked to pain and pancreatic neuritis in human chronic pancreatitis. Lab Invest (2009) 0.99
Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol (2002) 0.97
Significant differences in central imaging of histamine-induced itch between atopic dermatitis and healthy subjects. Eur J Pain (2008) 0.96
Central origin of secondary mechanical hyperalgesia. J Neurophysiol (2003) 0.96
Chemically and electrically induced sweating and flare reaction. Auton Neurosci (2004) 0.96
Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis--a retrospective study (FUTURE). J Dtsch Dermatol Ges (2009) 0.96
Health-Related Quality of Life in Chronic Pruritus: An Analysis Related to Disease Etiology, Clinical Skin Conditions and Itch Intensity. Dermatology (2015) 0.95
Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils. Exp Dermatol (2007) 0.95
Chronic pruritus: clinics and treatment. Ann Dermatol (2011) 0.94
Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans. Pain (2011) 0.92
European guideline on chronic pruritus. Acta Derm Venereol (2012) 0.92
No alpha-adrenoreceptor-induced C-fiber activation in healthy human skin. J Appl Physiol (1985) (2003) 0.92
Monocyte chemoattractant protein-1 in subcutaneous abdominal adipose tissue: characterization of interstitial concentration and regulation of gene expression by insulin. J Clin Endocrinol Metab (2007) 0.92
Neural activation during experimental allodynia: a functional magnetic resonance imaging study. Eur J Neurosci (2004) 0.91
Role of matriptase and proteinase-activated receptor-2 in nonmelanoma skin cancer. J Invest Dermatol (2009) 0.90
Chronic itch and pain--similarities and differences. Eur J Pain (2006) 0.90
In situ profiling of adipokines in subcutaneous microdialysates from lean and obese individuals. Am J Physiol Endocrinol Metab (2008) 0.90
Chronic pruritus: targets, mechanisms and future therapies. Drug News Perspect (2008) 0.90
Role of protease-activated receptors in human skin fibrosis and scleroderma. Exp Dermatol (2011) 0.90
Modeling activity-dependent changes of axonal spike conduction in primary afferent C-nociceptors. J Neurophysiol (2013) 0.90
Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. J Am Acad Dermatol (2002) 0.90
CIS-based registration of quality of life in a single source approach. BMC Med Inform Decis Mak (2011) 0.90
Polyneuropathy induced by HIV disease and antiretroviral therapy. Clin Neurophysiol (2012) 0.90
Alpha-melanocyte-stimulating hormone inhibits allergic airway inflammation. J Immunol (2003) 0.90
IL-18 reduces ultraviolet radiation-induced DNA damage and thereby affects photoimmunosuppression. J Immunol (2006) 0.90